Hypertension Research in Pregnancy
Online ISSN : 2187-9931
Print ISSN : 2187-5987
ISSN-L : 2187-5987

This article has now been updated. Please use the final version.

Primary aldosteronism during pregnancy: Case report and literature review
Hiromu OkakiYuko MatsumotoYuko MakinoYoshiyuki MorishitaKenjiro Takagi
Author information
JOURNAL OPEN ACCESS Advance online publication

Article ID: HRP2022-013

Details
Abstract

We present the case of a 40-year-old woman who experienced severe hypertension during her first pregnancy. Hypertension persisted after delivery, prompting admission to the Department of Endocrinology and Metabolism at our hospital. Examination revealed an aldosterone-producing adenoma, and she was diagnosed with primary aldosteronism. Her hypertension was controlled using methyldopa. She became pregnant again in April 2019, and in the ninth week of pregnancy, she underwent her first medical examination of the artery. Subsequently, the methyldopa dose was increased to control her hypertension. However, her hypertension worsened, and she tested positive for urinary albumin, prompting hospital admission at 32 weeks of gestation. Her oral medication was changed to nifedipine, which was continued after her second delivery. However, her hypertension persisted. Therefore, a selective mineralocorticoid receptor antagonist was administered, and her hypertension improved. Mineralocorticoid receptor antagonists should be considered when blood pressure is poorly controlled owing to worsening primary aldosteronism.

Content from these authors
© 2022 Japan Society for the Study of Hypertension in Pregnancy
feedback
Top